Reports for ASTELLAS PHARMA CANADA INC
Company Name
ASTELLAS PHARMA CANADA INC
Totals |
||
Shortage reports |
2 |
|
| Actual shortage: | 0 (0%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 0 (0%) | |
| Resolved: | 2 (100%) | |
Discontinuation Reports |
2 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 2 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
1 (25%) |
|
Overdue reports |
0 (0%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| VESICARE | 5MG | TABLET | Resolved | 2023-11-03 | 2023-11-11 | 208998 |
| VESICARE | 10MG | TABLET | Resolved | 2023-10-26 | 2023-11-11 | 208279 |
Showing 1 to 2 of 2
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ADENOCARD INJECTION -PRE-FILLED SYRINGE | 3MG | SOLUTION | Discontinued | 2018-01-02 | 2019-09-13 | 34494 |
| ADENOCARD INJECTION -PRE-FILLED SYRINGE | 3MG | SOLUTION | Discontinued | 2022-04-01 | 2022-04-01 | 157803 |
Showing 1 to 2 of 2